Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial.
Lorenz LeitnerWilbert SybesmaNina ChanishviliMarina GoderdzishviliArchil ChkhotuaAleksandre UjmajuridzeMarc P SchneiderAndrea SartoriUlrich MehnertLucas M BachmannThomas M KesslerPublished in: BMC urology (2017)
This study has been registered at clinicaltrials.gov ( www.clinicaltrials.gov/ct2/show/NCT03140085 ). April 27, 2017.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- urinary tract infection
- patients undergoing
- phase ii
- phase iii
- study protocol
- benign prostatic hyperplasia
- prostate cancer
- computed tomography
- open label
- randomized controlled trial
- phase ii study
- magnetic resonance imaging
- dual energy
- squamous cell carcinoma
- rectal cancer